Product Reports Resources Pricing Login Book a demo

Epoch Biodesign

Biotech & Life Sciences · London, United Kingdom · Founded 2019

Designing and scaling the first enzymes capable of transforming plastics into low-carbon, circular chemicals MoreLess

Epoch Biodesign is a pioneering startup focused on developing natural solutions to tackle environmental challenges, particularly plastic pollution. The company operates at the intersection of computational and biological sciences, leveraging the latest advancements in these fields to create innovative enzymatic processes. These enzymes are designed to break down plastics, offering a sustainable alternative to traditional recycling methods.

Epoch Biodesign serves a diverse range of clients, including industrial manufacturers, waste management companies, and environmental organizations. These clients are looking for effective and scalable solutions to manage plastic waste and reduce their environmental footprint. By providing these enzymatic solutions, Epoch helps its clients meet regulatory requirements and achieve their sustainability goals.

The market Epoch operates in is the environmental biotechnology sector, which is rapidly growing due to increasing awareness and regulatory pressure to address climate change and pollution. This market is characterized by a high demand for innovative technologies that can provide practical and scalable solutions to environmental problems.

Epoch Biodesign's business model is based on the development and commercialization of its proprietary enzymatic processes. The company generates revenue through licensing agreements, partnerships, and direct sales of its enzyme-based solutions. By collaborating with industry leaders and securing funding from investors like Lowercarbon Capital, Epoch is well-positioned to scale its operations and expand its market reach.

In summary, Epoch Biodesign is a forward-thinking company that combines expertise in computational and biological sciences to create groundbreaking enzymatic solutions for plastic waste management. By addressing a critical environmental issue, the company not only helps its clients achieve sustainability but also contributes to a healthier planet.

Keywords: enzymatic processes, plastic recycling, environmental biotechnology, sustainability, computational biology, biological sciences, industrial solutions, waste management, pollution control, innovative technology.

Company overview

Epoch Biodesign company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2019
Headquarters
London, United Kingdom
Employees
57
Open positions
2
Dealroom signal
91.2
client focusb2btechnologyHardwaretechnologyDeep Techsub industryBioTechnologybusiness modelManufacturingsectorRecyclingindustryHealthsectorBiotechnologysectorSynthetic BiologysectorSustainable Development GoalssectorAdvanced MaterialssectorClimate TechsectorCircular EconomysectorBIA Techbio UK

Valuation & funding

Epoch Biodesign funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCEquity / VC Mar 2026 $12M $92M Lululemon · Extantia Capital · KOMPAS VC · Happiness Capital
GRANTOther financing Mar 2025 $1M Government of the United Kingdom
SERIES AEquity / VC Mar 2025 $18M $73M Inditex · Happiness Capital · Kibo Invest · Lowercarbon Capital
GRANTOther financing Feb 2025 $924K UK Research and Innovation
SEEDEquity / VC Jun 2022 $11M $44M Zero Carbon Capital · The Venture Collective · MCJ Collective · Amadeus Capital Partners
SEEDEquity / VC Jan 2022 Plug and Play
GRANTOther financing Mar 2021 Undisclosed
GRANTOther financing Oct 2020 Undisclosed
GRANTOther financing Mar 2020 Undisclosed
SEEDEquity / VC Jul 2019 Undisclosed
Showing 10 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 80
2025 50
2024 29
2023 27
2022 20
2021 14
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Epoch Biodesign website traffic

Latest recorded traffic for Epoch Biodesign is 5.1K monthly website visits, up 6.3% over the last three months. Epoch Biodesign's team grew 14% over the past year.

Latest monthly visits5.1K 3-month web change+6.3% 1-year team growth+14%
Monthly website visits41 observations · Dec 2020–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Epoch Biodesign compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Epoch Biodesign's talent

Book a demo to see the people
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

23 investors on Epoch Biodesign's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 10 investors entered at this stage
Plug and Play
Zero Carbon Capital
The Venture Collective
MCJ Collective
Amadeus Capital Partners
BoxGroup
Lowercarbon Capital
VOYAGERS
UK Research and Innovation
Government of the United Kingdom
Series A 8 investors entered at this stage
Extantia Capital
Inditex
Happiness Capital
Kibo Invest
Day One Ventures
Lululemon
KOMPAS VC
Leitmotif
Other known 5 additional known investors
Cambridge Angels
Matthew Claxton
Net Zero Technology Centre
Planet Fund
Possible Ventures

Global footprint

Where Epoch Biodesign has talent and traffic

Workforce by country
5 countries with
team presence
🇬🇧 United Kingdom75.8%
🇪🇸 Spain15.2%
🇺🇸 United States6.1%
🇳🇱 Netherlands1.5%
🇩🇪 Germany1.5%
5 countries shown

In the news

Latest news about Epoch Biodesign

Recent press, funding announcements, and product moves mentioning Epoch Biodesign — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Epoch Biodesign

An AI-synthesized read of the highest-engagement posts about Epoch Biodesign on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Epoch Biodesign’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.